Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person pertuzumab [extracellular region]

Class:IdProteinDrug:9665971
_displayNamepertuzumab [extracellular region]
_timestamp2019-11-01 03:10:20
compartment[Compartment:984] extracellular region
created[InstanceEdit:9665965] Orlic-Milacic, Marija, 2019-11-01
disease[Disease:1500689] cancer
namepertuzumab
referenceEntity[ReferenceTherapeutic:9665970] pertuzumab [Guide to Pharmacology:5046]
stableIdentifier[StableIdentifier:9665981] R-ALL-9665971.1
(activeUnit)[NegativeRegulation:9665972] Negative regulation by 'ERBB2:pertuzumab:ERBIN:HSP90:CDC37 [plasma membrane]'
(hasComponent)[Complex:9665973] ERBB2 R678Q:pertuzumab [plasma membrane] [Homo sapiens]
[Complex:9665975] ERBB2:pertuzumab [plasma membrane] [Homo sapiens]
(input)[Reaction:9665703] ERBB2 TMD/JMD mutants bind pertuzumab [Homo sapiens]
[FailedReaction:9665708] ERBB2 TMD/JMD mutants do not bind pertuzumab [Homo sapiens]
[Reaction:9665726] ERBB2 binds pertuzumab [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by pertuzumab [extracellular region] (9665971)
Follow Reactome